Pluri Inc. Accumulated Other Comprehensive Income
Pluri Inc. (PLUR) had Accumulated Other Comprehensive Income of $5.38 million as of 2017-12-31, per its 10-Q filed 2018-02-06.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2018-09-12
- 2017-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.38M.
- 2017-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $944.00K.
- 2017-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.00M.
- 2017-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.44M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2017-12-31 | $5.38M 10-Q · filed 2018-02-06 |
| 2017-09-30 | $944.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.00M 10-K · filed 2018-09-12 |
| 2017-03-31 | $1.44M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $461.00K 10-Q · filed 2017-02-08 |
| 2016-09-30 | $2.06M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $1.48M 10-K · filed 2017-09-07 |
| 2016-03-31 | $931.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $768.00K 10-Q · filed 2016-02-08 |
| 2015-09-30 | $442.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $2.14M 10-K · filed 2016-09-07 |
| 2015-03-31 | $1.50M 10-Q · filed 2015-05-06 |
| 2014-12-31 | -$399.00K 10-Q · filed 2015-02-05 |
| 2014-09-30 | -$729.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $2.96M 10-K · filed 2015-09-09 |
| 2014-03-31 | $2.88M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.16M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $654.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $259.00K 10-K · filed 2014-09-11 |
| 2013-03-31 | $575.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $364.00 10-Q · filed 2013-01-31 |
| 2012-09-30 | $99.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | -$130.00K 10-K · filed 2013-09-11 |
| 2012-03-31 | $52.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | -$134.00K 10-Q · filed 2012-02-09 |
| 2011-09-30 | $1.00K 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |